US2020316001A1PendingUtilityA1
Composition for treating atopy or pruritus containing n-acetyl or n-acylamino acid
Est. expiryNov 24, 2037(~11.3 yrs left)· nominal 20-yr term from priority
Inventors:Myung-Kwan Han
A61P 17/00A61K 31/197A23V 2002/00A23L 33/175A61K 8/442A61Q 19/00A23L 33/10A61K 31/198A61P 17/04A61K 8/0212A23V 2200/318A61K 31/405A61Q 19/007A61K 2800/75A23L 33/40A61K 8/44A61K 8/4913A61K 8/492
49
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present disclosure relates to a composition for preventing, alleviating or treating pruritus and/or atopy using an N-acetylamino acid or an N-acylamino acid having almost no side effects on the human body. Also, the present disclosure relates to a cosmetic composition for moisturizing skin or soothing skin. The composition of the present disclosure may be utilized to ameliorate a problematic skin condition caused by various causes, or to safely and effectively alleviate or treat pruritus and/or atopy without concern about side effects.
Claims
exact text as granted — not AI-modified1 . A pharmaceutical composition for preventing or treating atopy or pruritus, comprising an N-acetylamino acid, an N-acylamino acid or a pharmaceutically acceptable salt thereof as an active ingredient.
2 . (canceled)
3 . (canceled)
4 . The pharmaceutical composition according to claim 1 , wherein the N-acetylamino acid is one or more amino acid selected from a group consisting of N-acetylalanine, N-acetylthreonine, N-acetylarginine and N-acetyltryptophan.
5 . The pharmaceutical composition according to claim 4 , wherein the N-acetylamino acid is one or more amino acid selected from a group consisting of N-acetyl-L-alanine, N-acetyl-L-threonine, N-acetyl-L-arginine and N-acetyl-L-tryptophan.
6 . The pharmaceutical composition according to claim 1 , wherein the N-acylamino acid is N-acyltryptophan or N-acylalanine.
7 . The pharmaceutical composition according to claim 6 , wherein the N-acylamino acid is N-acyl-L-tryptophan or N-acyl-L-alanine.
8 . The pharmaceutical composition according to claim 1 , wherein the pruritus is selected from a group consisting of vulvar pruritus, vaginal pruritus, paroxysmal pruritus, winter pruritus, anal pruritus, scrotal pruritus, aquagenic pruritus, scalp pruritus, nasal pruritus, oral pruritus and ocular pruritus.
9 . The pharmaceutical composition according to any of claim 1 , wherein the composition is prepared into a formulation selected from a group consisting of a formulation for external application to skin, an aerosol, a spray, a collyrium, an oral medication and an injection.
10 . A food composition for preventing or improving atopy or pruritus, comprising an N-acetylamino acid, an N-acylamino acid or a sitologically acceptable salt thereof as an active ingredient.
11 . (canceled)
12 . (canceled)
13 . A cosmetic composition for moisturizing skin or soothing skin, comprising an N-acetylamino acid, an N-acylamino acid or a cosmetically acceptable salt thereof as an active ingredient.
14 . The cosmetic composition according to claim 13 , wherein the cosmetic composition improves one or more skin condition selected from a group consisting of skin dryness, edema, erythema, inflammation, eschar, abrasion and lichenification.
15 . A cosmetic composition for preventing or improving atopy or pruritus, comprising an N-acetylamino acid, an N-acylamino acid or a cosmetically acceptable salt as an active ingredient.
16 . (canceled)
17 . (canceled)
18 . The cosmetic composition according to claim 13 , wherein the N-acetylamino acid is one or more amino acid selected from a group consisting of N-acetylalanine, N-acetylthreonine, N-acetylarginine and N-acetyltryptophan.
19 . The cosmetic composition according to claim 18 , wherein the N-acetylamino acid is one or more amino acid selected from a group consisting of N-acetyl-L-alanine, N-acetyl-L-threonine, N-acetyl-L-arginine and N-acetyl-L-tryptophan.
20 . The cosmetic composition according to claim 13 , wherein the N-acylamino acid is N-acyltryptophan or N-acylalanine.
21 . The cosmetic composition according to claim 20 , wherein the N-acylamino acid is N-acyl-L-tryptophan or N-acyl-L-alanine.
22 . The cosmetic composition according to claim 13 , wherein the cosmetic composition is formulated into a cream, a lotion, a skin softener, an essence or a mist.
23 . A mask pack comprising the cosmetic composition according to claim 13 .
24 . The cosmetic composition according to claim 15 , wherein the N-acetylamino acid is one or more amino acid selected from a group consisting of N-acetylalanine, N-acetylthreonine, N-acetylarginine and N-acetyltryptophan.
25 . The cosmetic composition according to claim 24 , wherein the N-acetylamino acid is one or more amino acid selected from a group consisting of N-acetyl-L-alanine, N-acetyl-L-threonine, N-acetyl-L-arginine and N-acetyl-L-tryptophan.
26 . The cosmetic composition according to claim 15 , wherein the N-acylamino acid is N-acyltryptophan or N-acylalanine.
27 . The cosmetic composition according to claim 26 , wherein the N-acylamino acid is N-acyl-L-tryptophan or N-acyl-L-alanine.
28 . The cosmetic composition according to claim 15 , wherein the cosmetic composition is formulated into a cream, a lotion, a skin softener, an essence or a mist.
29 . A mask pack comprising the cosmetic composition according to claim 15 .Join the waitlist — get patent alerts
Track US2020316001A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.